ASHLEE MICHNO: Open Payments
NPI 1801593942 · FAIRMONT, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$873 in 35 payments from 9 companies in 2025. Trend: 2023 $470 · 2024 $485 · 2025 $873
Food & beverage: $873
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 18 | $339 |
| AstraZeneca Pharmaceuticals LP | 4 | $309 |
| PFIZER INC. | 3 | $64 |
| Exact Sciences Corporation | 3 | $46 |
| Esperion Therapeutics, Inc. | 2 | $39 |
| GlaxoSmithKline, LLC. | 2 | $31 |
| ABBVIE INC. | 1 | $16 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $16 |
| Amgen Inc. | 1 | $14 |
Products named: BRILINTA, Wegovy, Rybelsus, Ozempic, PAXLOVID, NEXLETOL, FARXIGA, SHINGRIX.
Industry payments across WV — which companies pay providers there.
